Psyence Biomedical Ltd.
PBM
$5.21
-$0.445-7.88%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.37M | 3.11M | 2.85M | 2.14M | 1.65M |
| Depreciation & Amortization | 4.30K | 3.20K | 2.10K | 1.10K | 200.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.85M | 3.63M | 3.41M | 2.43M | 2.20M |
| Operating Income | -3.85M | -3.63M | -3.41M | -2.43M | -2.20M |
| Income Before Tax | -327.00K | -24.13M | -47.93M | -48.38M | -50.67M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.33 | -24.13 | -47.93 | -48.38 | -50.67 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -327.00K | -24.13M | -47.93M | -48.38M | -50.67M |
| EBIT | -3.85M | -3.63M | -3.41M | -2.43M | -2.20M |
| EBITDA | -3.85M | -3.63M | -3.41M | -2.25M | -1.29M |
| EPS Basic | 49.76 | -1.05K | -2.16K | -2.17K | -2.23K |
| Normalized Basic EPS | -44.73 | -52.06 | -59.40 | -42.04 | -26.10 |
| EPS Diluted | 49.74 | -1.05K | -2.16K | -2.17K | -2.23K |
| Normalized Diluted EPS | -44.72 | -52.05 | -59.39 | -42.04 | -26.10 |
| Average Basic Shares Outstanding | 777.80K | 443.10K | 108.40K | 96.10K | 67.20K |
| Average Diluted Shares Outstanding | 777.90K | 443.20K | 108.50K | 96.20K | 67.20K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |